The expression of FOXP3 in PBMCs isolated from patients with moderate asthma (2.33±0.90) was higher than that of the ones with severe asthma (1.12±0.33) as well as the healthy subjects, but the differences were not statistically significant (Figure 6). This evidence concerns the gene FOXP3 and asthma.